Home Cart Sign in  
Chemical Structure| 1075236-89-3 Chemical Structure| 1075236-89-3

Structure of Gepotidacin
CAS No.: 1075236-89-3

Chemical Structure| 1075236-89-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor.

Synonyms: GSK2140944

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Gepotidacin

CAS No. :1075236-89-3
Formula : C24H28N6O3
M.W : 448.52
SMILES Code : O=C(C=NC(C=C1)=C23)N3[C@H](CN4CCC(NCC5=CC(CCCO6)=C6C=N5)CC4)CN2C1=O
Synonyms :
GSK2140944
MDL No. :MFCD27987926

Safety of Gepotidacin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Gepotidacin

DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05271799 Healthy Volunteers PHASE1 COMPLETED 2022-04-22 GSK Investigational Site, Las ... More >>Vegas, Nevada, 89113, United States Less <<
NCT02294682 Gonorrhea PHASE2 COMPLETED 2016-07-27 GSK Investigational Site, Foun... More >>tain Valley, California, 92708, United States|GSK Investigational Site, Los Angeles, California, 90028, United States|GSK Investigational Site, Los Angeles, California, 90069, United States|GSK Investigational Site, Palm Springs, California, 92262, United States|GSK Investigational Site, San Francisco, California, 94103, United States|GSK Investigational Site, Orlando, Florida, 32806, United States|GSK Investigational Site, Atlanta, Georgia, 30308, United States|GSK Investigational Site, Indianapolis, Indiana, 46202, United States|GSK Investigational Site, New Orleans, Louisiana, 70119, United States|GSK Investigational Site, Omaha, Nebraska, 68114, United States|GSK Investigational Site, Cleveland, Ohio, 44109, United States|GSK Investigational Site, Jenkintown, Pennsylvania, 19046, United States|GSK Investigational Site, San Juan, 00927, Puerto Rico|GSK Investigational Site, London, SW10 9NH, United Kingdom Less <<
NCT03562117 Infections, Bacterial PHASE1 COMPLETED 2018-12-26 GSK Investigational Site, Miam... More >>i, Florida, 33136, United States|GSK Investigational Site, Orlando, Florida, 32809, United States Less <<
NCT03568942 Infections, Bacterial PHASE2 COMPLETED 2019-01-07 GSK Investigational Site, La M... More >>esa, California, 91942, United States Less <<
NCT06597344 Urinary Tract Infections PHASE3 RECRUITING 2025-03-19 GSK Investigational Site, Birm... More >>ingham, Alabama, 35205-1628, United States|GSK Investigational Site, Modesto, California, 95350-5365, United States|GSK Investigational Site, North Hollywood, California, 91606-3287, United States|GSK Investigational Site, Pasadena, California, 91101-2453, United States|GSK Investigational Site, San Diego, California, 92120-5259, United States|GSK Investigational Site, Valencia, California, 91355, United States|GSK Investigational Site, Hialeah, Florida, 33016, United States|GSK Investigational Site, Miami, Florida, 33135, United States|GSK Investigational Site, Ormond Beach, Florida, 32174-6302, United States|GSK Investigational Site, Palm Springs, Florida, 33406-7671, United States|GSK Investigational Site, Palm Springs, Florida, 33461, United States|GSK Investigational Site, Plant City, Florida, 33563-4202, United States|GSK Investigational Site, Sweetwater, Florida, 33172-2741, United States|GSK Investigational Site, West Palm Beach, Florida, 33409-3401, United States|GSK Investigational Site, Smyrna, Georgia, 30082-5192, United States|GSK Investigational Site, East Brunswick, New Jersey, 08816-1407, United States|GSK Investigational Site, New York, New York, 10016-7313, United States|GSK Investigational Site, Columbus, Ohio, 43228, United States|GSK Investigational Site, Scottdale, Pennsylvania, 15683, United States|GSK Investigational Site, Forney, Texas, 75126-4174, United States|GSK Investigational Site, Houston, Texas, 77036, United States|GSK Investigational Site, Houston, Texas, 77054, United States|GSK Investigational Site, Houston, Texas, 77087, United States|GSK Investigational Site, Kingwood, Texas, 26537, United States|GSK Investigational Site, Mesquite, Texas, 75149, United States|GSK Investigational Site, Missouri City, Texas, 77459-4756, United States|GSK Investigational Site, Bountiful, Utah, 84010-4943, United States Less <<
NCT02729038 Infections, Bacterial PHASE1 COMPLETED 2017-06-20 GSK Investigational Site, Miam... More >>i, Florida, 33136, United States|GSK Investigational Site, Orlando, Florida, 32809, United States|GSK Investigational Site, Minneapolis, Minnesota, 55404, United States Less <<
NCT04484740 Gonorrhea|Infection, Bacterial PHASE1 COMPLETED 2023-05-27 MUVienna, Vienne, 1090, Austri... More >>a|CHU POITIERS Département ORL, Poitiers, 86021, France|CHU POITIERS Département Urologie, Poitiers, 86021, France|CHRU TOURS Département Urologie, Tours, 37000, France Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.23mL

0.45mL

0.22mL

11.15mL

2.23mL

1.11mL

22.30mL

4.46mL

2.23mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories